0,797  0,012  Caspase 9 stimulant
0,752  0,004  Antimutagenic
0,665  0,004  Genotoxic
0,687  0,033  Apoptosis agonist
0,648  0,010  5 Hydroxytryptamine release stimulant
0,644  0,025  Antineoplastic (lung cancer)
0,622  0,010  Cardiovascular analeptic
0,619  0,009  Caspase 3 stimulant
0,616  0,013  CYP1A2 substrate
0,606  0,005  FMO1 substrate
0,619  0,021  GST A substrate
0,604  0,013  CYP2D6 substrate
0,596  0,018  Respiratory analeptic
0,594  0,021  CYP2C9 substrate
0,583  0,011  Antineoplastic (non-small cell lung cancer)
0,580  0,009  Cardiodepressant
0,571  0,004  UGT2B4 substrate
0,601  0,053  Antiinflammatory
0,559  0,013  NOS2 expression inhibitor
0,554  0,009  Superoxide dismutase inhibitor
0,575  0,034  Transcription factor NF kappa B inhibitor
0,531  0,006  Anesthetic general
0,543  0,019  Antineoplastic (melanoma)
0,551  0,044  Antineoplastic (breast cancer)
0,540  0,037  TNF expression inhibitor
0,524  0,035  Antileukemic
0,510  0,022  Sensitization
0,489  0,005  5 Hydroxytryptamine uptake stimulant
0,507  0,026  CYP2C19 substrate
0,500  0,021  12-Lipoxygenase inhibitor
0,492  0,021  Antioxidant
0,482  0,025  Radioprotector
0,471  0,019  Free radical scavenger
0,458  0,007  FMO3 substrate
0,475  0,025  Analeptic
0,479  0,032  GABA C receptor rho-3 antagonist
0,467  0,026  AR expression inhibitor
0,445  0,006  GST P1-1 substrate
0,474  0,047  15-Lipoxygenase inhibitor
0,434  0,010  UGT1A3 substrate
0,448  0,024  Antineoplastic (multiple myeloma)
0,436  0,014  UGT1A1 substrate
0,463  0,041  Antineoplastic (colorectal cancer)
0,426  0,007  UGT2B15 substrate
0,443  0,024  Antiprotozoal (Leishmania)
0,430  0,012  UGT1A4 substrate
0,456  0,040  Antineoplastic (colon cancer)
0,455  0,039  Angiogenesis inhibitor
0,428  0,016  Calcium channel activator
0,450  0,040  CYP2C19 inhibitor
0,417  0,008  Pneumotoxic
0,420  0,011  Tubulin antagonist
0,426  0,018  Sigma receptor agonist
0,453  0,046  Immunosuppressant
0,425  0,019  Antihypertriglyceridemic
0,432  0,030  Lipoxygenase inhibitor
0,431  0,031  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,415  0,018  Sedative
0,447  0,051  CYP3A4 substrate
0,417  0,024  Tumour necrosis factor alpha release inhibitor
0,436  0,043  Ulceration
0,417  0,025  Antipyretic
0,394  0,002  UGT2B10 substrate
0,423  0,032  Antineoplastic (glioma)
0,431  0,045  Prostate cancer treatment
0,395  0,012  Melanin inhibitor
0,408  0,026  Antineoplastic (glioblastoma multiforme)
0,388  0,006  Carcinogenic, group 2B
0,395  0,013  Antiseptic
0,421  0,040  Antihypercholesterolemic
0,409  0,033  Chemoprotective
0,410  0,037  Antineoplastic (brain cancer)
0,399  0,028  Chemopreventive
0,396  0,026  Nitric oxide antagonist
0,416  0,046  Cholesterol antagonist
0,395  0,025  UGT1A6 substrate
0,426  0,057  Antipruritic, allergic
0,396  0,027  Antineoplastic (lymphoma)
0,382  0,021  Flavin-containing monooxygenase substrate
0,403  0,044  Antineoplastic (ovarian cancer)
0,375  0,016  GST M1-1 substrate
0,395  0,038  CTGF expression inhibitor
0,390  0,038  Antineoplastic (cervical cancer)
0,383  0,035  CYP1A2 inhibitor
0,387  0,041  Antineoplastic (pancreatic cancer)
0,351  0,006  Carcinogenic, group 1
0,354  0,011  NOS3 expression enhancer
0,353  0,014  VCAM1 expression inhibitor
0,342  0,004  Vanilloid 1 agonist
0,351  0,016  Skin whitener
0,352  0,020  Skin irritative effect
0,348  0,017  Tyrosine 3 hydroxylase inhibitor
0,376  0,045  Spasmolytic
0,370  0,042  UGT1A9 substrate
0,372  0,045  Vasodilator, coronary
0,357  0,034  Antineoplastic (renal cancer)
0,341  0,020  Antihypotensive
0,345  0,023  Muscle relaxant
0,325  0,005  Phosphodiesterase 4D inhibitor
0,356  0,038  Proliferative diseases treatment
0,330  0,015  5 Hydroxytryptamine 1E antagonist
0,327  0,014  Tumour necrosis factor antagonist
0,350  0,038  Carcinogenic
0,390  0,081  Histamine release inhibitor
0,342  0,034  Antimitotic
0,359  0,053  Aldehyde oxidase inhibitor
0,314  0,010  Sulfotransferase substrate
0,354  0,050  CYP3A4 inhibitor
0,340  0,038  Antineoplastic (endocrine cancer)
0,353  0,051  Cardioprotectant
0,319  0,018  Carcinogenic, group 3
0,365  0,068  Vasodilator, peripheral
0,355  0,063  Antithrombotic
0,307  0,016  CYP2B6 inhibitor
0,381  0,090  5 Hydroxytryptamine release inhibitor
0,309  0,020  Antineoplastic (carcinoma)
0,327  0,041  Antineoplastic (liver cancer)
0,328  0,046  Cytostatic
0,302  0,021  Skeletal muscle relaxant
0,292  0,012  Succinate dehydrogenase inhibitor
0,331  0,052  Hypoxia-inducible factor 1 alpha inhibitor
0,347  0,068  Antiallergic
0,307  0,034  Abortion inducer
0,301  0,033  ErbB-1 antagonist
0,289  0,021  Neurotrophic factor enhancer
0,307  0,041  Antiulcerative
0,316  0,051  Antiprotozoal (Trypanosoma)
0,267  0,005  TRPA1 agonist
0,302  0,042  Psychostimulant
0,268  0,009  GABA C receptor rho-2 antagonist
0,288  0,031  DNA methyltransferase I inhibitor
0,271  0,014  LDLR expression enhancer
0,312  0,055  Antihypoxic
0,272  0,015  UGT2B9 substrate
0,264  0,008  Cyclooxygenase 3 inhibitor
0,260  0,005  Vanilloid agonist
0,270  0,016  Anesthetic local
0,263  0,010  Neurotrophic factor
0,261  0,009  Breast cancer-resistant protein inhibitor
0,299  0,048  Vasodilator
0,271  0,021  Monophenol monooxygenase inhibitor
0,281  0,033  Non-steroidal antiinflammatory agent
0,271  0,025  Anesthetic
0,249  0,005  Carcinogenic, group 2A
0,274  0,033  UGT2B7 substrate
0,293  0,052  Cytotoxic
0,276  0,036  DNA methylase inhibitor
0,299  0,059  Insulysin inhibitor
0,272  0,035  P-glycoprotein inhibitor
0,336  0,100  Antiprotozoal
0,262  0,026  Antineoplastic (gastric cancer)
0,263  0,027  Protein-tyrosine phosphatase inhibitor
0,261  0,025  Amylase inhibitor
0,364  0,129  Alpha-glucosidase inhibitor
0,281  0,047  Mutagenic
0,283  0,049  Antineoplastic (sarcoma)
0,302  0,068  Antineoplastic (osteosarcoma)
0,297  0,063  Teratogen
0,257  0,027  Interferon gamma antagonist
0,244  0,018  Protein-tyrosine phosphatase 1B inhibitor
0,234  0,009  Phosphodiesterase IV inhibitor
0,230  0,006  Electron transport complex I inhibitor
0,283  0,062  Transcription factor STAT3 inhibitor
0,284  0,063  Embryotoxic
0,303  0,087  ICAM1 expression inhibitor
0,245  0,031  Antineoplastic (squamous cell carcinoma)
0,317  0,104  CYP2C9 inhibitor
0,215  0,003  UGT2B11 substrate
0,273  0,064  Hypoglycemic
0,216  0,008  Papain-like protease (SARS coronavirus) inhibitor
0,266  0,058  Antineoplastic (lymphocytic leukemia)
0,215  0,008  Adenylate cyclase stimulant
0,222  0,016  Expectorant
0,216  0,010  Mucolytic
0,273  0,068  Radiosensitizer
0,244  0,041  I kappa B kinase epsilon inhibitor
0,242  0,039  Insulin sensitizer
0,288  0,086  Antifungal
0,221  0,019  Alpha 2b adrenoreceptor antagonist
0,221  0,020  5-Lipoxygenase inhibitor
0,240  0,039  Eye irritation, high
0,216  0,017  Toll-Like receptor 2 antagonist
0,239  0,039  Antipruritic, non-allergic
0,343  0,145  Antineoplastic (solid tumors)
0,239  0,041  Nitric-oxide synthase stimulant
0,290  0,092  Apoptosis antagonist
0,226  0,029  Aldehyde oxidase substrate
0,214  0,017  Microtubule formation inhibitor
0,256  0,059  Pyruvate kinase inhibitor
0,241  0,046  Antiviral (West Nile virus)
0,253  0,059  Antiparasitic
0,258  0,064  Antiglaucomic
0,277  0,086  NOS3 expression inhibitor
0,328  0,140  Transcription factor inhibitor
0,193  0,007  Prostaglandin EP2 antagonist
0,211  0,027  MAO A inhibitor
0,257  0,076  DNA damaging
0,189  0,008  Beta tubulin antagonist
0,234  0,055  UDP-glucuronosyltransferase substrate
0,206  0,027  Arachidonic acid antagonist
0,204  0,026  Cholesterol synthesis inhibitor
0,240  0,061  Amyloid beta aggregation inhibitor
0,182  0,006  Antifungal (Pneumocystis)
0,198  0,023  CF transmembrane conductance regulator agonist
0,231  0,056  Platelet adhesion inhibitor
0,186  0,013  Sphingomyelinase inhibitor
0,205  0,032  Cyclooxygenase 1 inhibitor
0,192  0,020  Alpha 2c adrenoreceptor antagonist
0,205  0,032  Neurotensin receptor agonist
0,257  0,086  Lipoprotein disorders treatment
0,200  0,030  SULT1A3 substrate
0,189  0,019  Coagulant
0,188  0,018  UGT2B1 substrate
0,203  0,035  Uterine stimulant
0,193  0,026  Cystathionine beta-synthase inhibitor
0,200  0,037  ATPase inhibitor
0,249  0,087  Transcription factor STAT inhibitor
0,177  0,017  Calcium antagonist
0,163  0,004  Melatonin agonist
0,188  0,030  Epidermal growth factor receptor kinase inhibitor
0,199  0,042  Protein kinase stimulant
0,213  0,057  Hepatoprotectant
0,169  0,015  GABA C receptor rho-1 antagonist
0,177  0,023  Choleretic
0,167  0,013  Transcription factor NF kappa B stimulant
0,164  0,010  Antiviral (SARS coronavirus)
0,164  0,010  Antiviral (Coronavirus)
0,197  0,043  Lipid peroxidase inhibitor
0,170  0,017  Heat shock protein 70 antagonist
0,213  0,061  Antihelmintic
0,229  0,078  Hypolipemic
0,194  0,043  MAO inhibitor
0,154  0,004  Melatonin 2 agonist
0,187  0,039  Alkaline phosphatase inhibitor
0,291  0,143  Antibacterial
0,161  0,014  Inducible nitric-oxide synthase inhibitor
0,172  0,026  SULT1A1 substrate
0,264  0,120  Prostaglandin dehydrogenase inhibitor
0,197  0,053  Antianorexic
0,164  0,021  HIV-1 integrase (Overall Integration) inhibitor
0,182  0,039  Antifungal enhancer
0,169  0,028  Xanthine oxidase inhibitor
0,199  0,058  VEGF expression inhibitor
0,155  0,015  CYP2A6 inhibitor
0,188  0,048  Phobic disorders treatment
0,154  0,014  Acetylcholine release stimulant
0,219  0,080  Cyclic AMP phosphodiesterase inhibitor
0,171  0,033  Glutathione S-transferase substrate
0,141  0,004  Exportin-1 inhibitor
0,161  0,026  Contraceptive female
0,165  0,030  Interleukin 1b antagonist
0,187  0,054  Phospholipase C inhibitor
0,146  0,013  Phosphodiesterase 4B inhibitor
0,220  0,087  Antiamyloidogenic
0,209  0,077  Antineoplastic enhancer
0,165  0,035  Antiprotozoal (Amoeba)
0,168  0,038  Antieczematic
0,203  0,074  Septic shock treatment
0,161  0,033  Beta amyloid protein antagonist
0,138  0,010  GABA aminotransferase inhibitor
0,155  0,027  GABA C receptor antagonist
0,231  0,104  Gastrin inhibitor
0,139  0,012  Antifungal (Aspergillus)
0,227  0,101  Antineoplastic (bladder cancer)
0,184  0,062  3C-like protease (Human coronavirus) inhibitor
0,152  0,030  Photosensitizer
0,126  0,005  Potassium channel Kv1.3 blocker
0,144  0,025  Prolactin inhibitor
0,165  0,047  Acetylcholinesterase inhibitor
0,130  0,012  Alpha tubulin antagonist
0,141  0,024  Carbonic anhydrase XIII inhibitor
0,151  0,037  Gastritis treatment
0,130  0,017  Alpha 2d adrenoreceptor antagonist
0,233  0,119  CYP2D6 inhibitor
0,118  0,005  Squalene synthetase inhibitor
0,121  0,008  Endocannabinoid uptake inhibitor
0,180  0,067  Antirickettsial
0,117  0,004  Calcium channel P-type blocker
0,137  0,025  Anabolic
0,172  0,061  Cytidine deaminase inhibitor
0,191  0,080  5 Hydroxytryptamine 3E antagonist
0,160  0,049  NADPH oxidase inhibitor
0,171  0,060  Acaricide
0,234  0,125  Bone diseases treatment
0,136  0,026  Antispirochetal
0,138  0,028  Toll-Like receptor 4 antagonist
0,138  0,029  DOPA decarboxylase inhibitor
0,134  0,026  GST T1-1 substrate
0,121  0,012  Narcotic antagonist
0,153  0,044  Antihemorrhagic
0,157  0,049  Antifungal (Cryptococcus)
0,248  0,141  Antiprotozoal (Plasmodium)
0,214  0,108  Interleukin agonist
0,149  0,044  Ca2+-transporting ATPase inhibitor
0,117  0,012  Ca(v)3.1 blocker
0,280  0,176  DNA polymerase beta inhibitor
0,133  0,030  Nitric-oxide synthase inhibitor
0,148  0,047  Antibacterial (Helicobacter pylori)
0,186  0,086  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,169  0,069  Peroxidase inhibitor
0,275  0,176  DNA directed DNA polymerase inhibitor
0,121  0,022  Glutathione S-transferase inhibitor
0,118  0,019  Nicotinic alpha4beta2 receptor antagonist
0,136  0,038  Aldehyde dehydrogenase substrate
0,131  0,033  Antiprotozoal (Toxoplasma)
0,122  0,024  Ornithine decarboxylase inhibitor
0,134  0,037  Mediator release inhibitor
0,106  0,009  Leukotriene B4 antagonist
0,131  0,035  Urease inhibitor
0,124  0,028  ErbB-3 antagonist
0,114  0,020  Granulocyte macrophage colony stimulating factor agonist
0,133  0,038  Bronchodilator
0,159  0,066  Phospholipase A2 inhibitor
0,109  0,016  Estrogen-related receptor beta agonist
0,115  0,023  Glutamate decarboxylase inhibitor
0,112  0,020  Leukotriene synthesis inhibitor
0,127  0,035  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,114  0,025  Bile acid receptor antagonist
0,093  0,005  Adenylate cyclase 1 inhibitor
0,107  0,019  Leukotriene antagonist
0,123  0,035  Alpha 2 adrenoreceptor antagonist
0,134  0,046  Alcohol dehydrogenase substrate
0,195  0,107  RNA-directed DNA polymerase inhibitor
0,091  0,004  Melatonin 1 agonist
0,107  0,020  Aromatase inhibitor
0,101  0,014  Alpha 2 adrenoreceptor agonist
0,090  0,004  Melatonin receptor 1A agonist
0,101  0,016  Beta adrenoreceptor antagonist
0,129  0,044  GABA C receptor agonist
0,093  0,009  Transcription factor RelA inhibitor
0,099  0,015  Beta 3 adrenoreceptor antagonist
0,091  0,007  Anesthetic inhalation
0,094  0,011  Fibroblast growth factor 4 antagonist
0,142  0,059  Cocaine dependence treatment
0,151  0,069  Cyclooxygenase inhibitor
0,088  0,005  Ryanodine receptor antagonist
0,110  0,029  Tocolytic
0,133  0,054  Antiviral (Papilloma)
0,179  0,101  Histone acetyltransferase inhibitor
0,148  0,070  Hair growth stimulant
0,094  0,017  5 Hydroxytryptamine 2A agonist
0,148  0,071  Hemostatic
0,101  0,024  Calcium channel L-type blocker
0,084  0,008  Lysophosphatidic acid 3 receptor antagonist
0,112  0,037  Epidermal growth factor antagonist
0,127  0,052  Shock treatment
0,084  0,010  Glucose-6-phosphate translocase inhibitor
0,132  0,057  Proteasome inhibitor
0,278  0,204  MAP kinase 1 inhibitor
0,118  0,044  Dementia treatment
0,084  0,011  Postcoital contraceptive
0,109  0,036  Antidote, mercury
0,119  0,047  Carbonic anhydrase XV inhibitor
0,085  0,013  Sphingosine kinase 2 inhibitor
0,119  0,047  Butyrylcholinesterase inhibitor
0,080  0,008  TRPM8 blocker
0,080  0,009  Vanilloid 2 antagonist
0,078  0,008  Factor III inhibitor
0,122  0,052  Estrogen antagonist
0,104  0,034  Alpha 2a adrenoreceptor antagonist
0,100  0,030  Keratolytic
0,113  0,044  Vascular dementia treatment
0,134  0,065  Sphingosine 1-phosphate receptor 2 antagonist
0,101  0,032  Glycine receptor antagonist
0,111  0,042  Tourette's syndrome treatment
0,177  0,108  Antiparkinsonian, rigidity relieving
0,074  0,005  Dihydrofolate reductase inhibitor
0,119  0,051  MAO B inhibitor
0,137  0,070  CNS active muscle relaxant
0,096  0,030  Estrogen receptor alpha antagonist
0,101  0,034  Macrophage migration inhibitory factor inhibitor
0,095  0,030  Alpha adrenoreceptor agonist
0,106  0,040  Antifungal (Candida)
0,084  0,019  Phosphodiesterase 4A inhibitor
0,081  0,016  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,109  0,044  Glutamate (mGluR7) agonist
0,074  0,010  Pregnane X receptor antagonist
0,118  0,055  Ferrochelatase inhibitor
0,102  0,039  ErbB-4 antagonist
0,092  0,030  Phenylalanine 4-hydroxylase inhibitor
0,233  0,171  Antineoplastic (small cell lung cancer)
0,118  0,056  Excitatory amino acid transporter EAAC1 inhibitor
0,070  0,008  Dopamine beta hydroxylase inhibitor
0,132  0,070  Interleukin 4 antagonist
0,109  0,048  Estrogen receptor beta antagonist
0,079  0,018  Beta 1 adrenoreceptor antagonist
0,071  0,010  Retinoid X receptor agonist
0,068  0,009  Retinoid X alpha receptor agonist
0,103  0,045  Thioredoxin inhibitor
0,127  0,069  Antineoplastic (uterine cancer)
0,166  0,110  Platelet aggregation inhibitor
0,071  0,016  Dihydroorotate oxidase inhibitor
0,157  0,102  Antineoplastic (bone cancer)
0,101  0,046  Triose-phosphate isomerase inhibitor
0,063  0,009  Diamine oxidase inhibitor
0,110  0,056  Beta glucuronidase inhibitor
0,122  0,068  Sphingosine 1-phosphate receptor 4 antagonist
0,093  0,039  Phosphodiesterase XI inhibitor
0,093  0,039  Phosphodiesterase 11A inhibitor
0,079  0,026  SULT2A1 substrate
0,078  0,024  Antimycoplasmal
0,114  0,061  Myasthenia Gravis treatment
0,108  0,055  Adenylate kinase inhibitor
0,085  0,033  Glycine receptor agonist
0,188  0,136  Antiosteoporotic
0,145  0,092  Antihelmintic (Nematodes)
0,059  0,009  Vesicle monoamine transporter inhibitor
0,068  0,018  Beta 2 adrenoreceptor antagonist
0,098  0,048  Androgen antagonist
0,143  0,093  Growth hormone agonist
0,059  0,010  Inosine monophosphate dehydrogenase inhibitor
0,093  0,044  Carbonic anhydrase VI inhibitor
0,076  0,028  TRPA1 antagonist
0,083  0,035  Amidase inhibitor
0,078  0,030  Glutamate (mGluR7) antagonist
0,056  0,009  Kainate receptor agonist
0,067  0,020  Nicotinic alpha3beta2 receptor antagonist
0,100  0,052  Phosphodiesterase 6D inhibitor
0,116  0,069  Cell adhesion inhibitor
0,054  0,008  Lysophosphatidic acid 2 receptor antagonist
0,092  0,045  Topoisomerase II alpha inhibitor
0,094  0,048  ATPase (Vacuolar H+) inhibitor
0,137  0,092  Raynaud's phenomenon treatment
0,122  0,077  Antihyperlipoproteinemic
0,084  0,039  Phosphofructokinase-1 inhibitor
0,084  0,039  Lipase inhibitor
0,087  0,043  Na+ K+ transporting ATPase inhibitor
0,134  0,090  Thiol protease inhibitor
0,103  0,059  Carbonic anhydrase III inhibitor
0,114  0,071  Antiprotozoal (Babesia)
0,139  0,096  Movement disorders treatment
0,134  0,092  Neuropeptide Y1 antagonist
0,080  0,037  Carbonic anhydrase VA inhibitor
0,120  0,078  Alpha-N-acetylglucosaminidase inhibitor
0,046  0,004  Imidazoline I1 receptor antagonist
0,050  0,009  Vanilloid 3 antagonist
0,087  0,047  Thioredoxin reductase inhibitor
0,133  0,093  Insulin secretagoues
0,082  0,042  MAP kinase kinase 7 inhibitor
0,175  0,136  Immunostimulant
0,102  0,063  Gastric antisecretory
0,051  0,012  5 Hydroxytryptamine 2B agonist
0,080  0,042  Histidine decarboxylase inhibitor
0,080  0,042  Phosphodiesterase VI inhibitor
0,053  0,015  Dopamine D5 agonist
0,074  0,036  Hyperparathyroidism treatment
0,095  0,057  Antiviral (Rhinovirus)
0,046  0,009  Leukotriene B4 receptor 1 antagonist
0,114  0,077  Aldehyde dehydrogenase inhibitor
0,118  0,082  Cyclooxygenase 2 inhibitor
0,198  0,163  Thyroid hormone antagonist
0,065  0,031  Sphingosine kinase inhibitor
0,078  0,045  GABA B receptor agonist
0,081  0,048  Antidote, organophosphates
0,244  0,212  Calcium channel L-type activator
0,042  0,010  Adenosine uptake inhibitor
0,046  0,014  Peroxisome proliferator-activated receptor delta agonist
0,192  0,161  Thyroid hormone beta antagonist
0,101  0,070  Falcipain 3 inhibitor
0,118  0,087  Bone formation stimulant
0,048  0,017  Heme oxygenase inhibitor
0,060  0,029  Leukotriene C antagonist
0,048  0,018  Dihydropteroate synthase inhibitor
0,034  0,004  Alpha 2b adrenoreceptor agonist
0,172  0,142  Peptidyltransferase inhibitor
0,075  0,045  Prokinetic
0,071  0,042  Carbonic anhydrase V inhibitor
0,084  0,055  Antiprotozoal activity enhancer
0,106  0,077  Antitussive
0,127  0,098  Antidote
0,040  0,012  Uridine phosphorylase inhibitor
0,102  0,075  Multidrug resistance-associated protein 1 inhibitor
0,069  0,042  Fibroblast growth factor 2 antagonist
0,030  0,005  Neuraminidase (Influenza B) inhibitor
0,117  0,091  Calcium channel blocker
0,049  0,024  Leukocyte elastase inhibitor
0,042  0,018  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,029  0,005  Alpha 2c adrenoreceptor agonist
0,093  0,069  Electrolyte absorption antagonist
0,050  0,027  Oleamide hydrolase inhibitor
0,111  0,088  Cathepsin H inhibitor
0,059  0,036  Phosphodiesterase 4C inhibitor
0,027  0,004  Melatonin receptor 1A antagonist
0,063  0,040  Neuraminidase inhibitor
0,080  0,058  Adrenaline agonist
0,031  0,009  Vanilloid 2 agonist
0,058  0,037  Carbonic anhydrase VB inhibitor
0,075  0,054  SULT1A2 substrate
0,047  0,026  Estradiol 17 beta-dehydrogenase inhibitor
0,158  0,137  Antialcoholic
0,124  0,103  Cholinergic
0,114  0,094  Antihelmintic (Trematoda)
0,075  0,055  NAD(P)H dehydrogenase (quinone) inhibitor
0,203  0,184  Calpain 2 inhibitor
0,082  0,063  Myeloperoxidase inhibitor
0,070  0,052  Peroxisome proliferator-activated receptor gamma antagonist
0,031  0,012  Nicotinic acid receptor 2 antagonist
0,064  0,046  Dopamine D1 antagonist
0,060  0,041  Androgen agonist
0,059  0,041  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,056  0,038  5 Hydroxytryptamine 7 agonist
0,036  0,018  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,072  0,054  S-adenosyl-L-methionine decarboxylase inhibitor
0,041  0,024  VCAM-1 antagonist
0,026  0,009  Inosine monophosphate dehydrogenase 2 inhibitor
0,040  0,024  VCAM antagonist
0,060  0,044  5 Hydroxytryptamine 5A antagonist
0,123  0,108  Heat shock protein 90 antagonist
0,019  0,004  Melatonin 2 antagonist
0,039  0,024  5-Alpha-reductase inhibitor
0,054  0,040  Epithelial sodium channel blocker
0,066  0,052  Peroxisome proliferator-activated receptor gamma agonist
0,071  0,057  Arylamine N-Acetyltransferase substrate
0,055  0,042  Fatty acid synthase inhibitor
0,028  0,015  Sodium/glucose cotransporter 2 inhibitor
0,032  0,019  Prostaglandin EP3 antagonist
0,166  0,154  Calpain inhibitor
0,056  0,044  5 Hydroxytryptamine 5 antagonist
0,038  0,026  Glutamate (mGluR8) agonist
0,022  0,011  Factor XIII inhibitor
0,050  0,038  Aconitate hydratase inhibitor
0,054  0,043  Xanthine dehydrogenase inhibitor
0,061  0,050  Protease 3C (Human rhinovirus) inhibitor
0,039  0,028  Leukotriene C4 antagonist
0,023  0,012  Lysophosphatidic acid 1 receptor antagonist
0,073  0,063  Acetylcholine nicotinic antagonist
0,064  0,055  Elastase 1 inhibitor
0,199  0,189  Sodium/bile acid cotransporter inhibitor
0,067  0,058  Cathepsin G inhibitor
0,055  0,046  Biliverdin reductase inhibitor
0,045  0,036  CC chemokine 4 receptor antagonist
0,052  0,044  Bruton tyrosine kinase inhibitor
0,034  0,025  Progesterone antagonist
0,078  0,070  Histamine H2 receptor antagonist
0,034  0,026  Phosphoglycerate kinase inhibitor
0,077  0,069  Caspase 7 inhibitor
0,043  0,036  Carbonic anhydrase VII inhibitor
0,047  0,039  Antiviral (Herpesvirus 3, Human)
0,068  0,060  Glutamate dehydrogenase inhibitor
0,013  0,006  Imidazoline I2 receptor antagonist
0,040  0,033  Guanylate cyclase inhibitor
0,050  0,043  Postmenopausal disorders treatment
0,023  0,016  Prostaglandin F2 alpha agonist
0,044  0,037  Peroxisome proliferator-activated receptor alpha agonist
0,053  0,046  Dopamine uptake inhibitor
0,030  0,024  Cholesterol ester transfer protein antagonist
0,027  0,022  DNA polymerase III inhibitor
0,067  0,062  CDC25A inhibitor
0,018  0,012  Antibiotic Trimethoprim-like
0,086  0,080  Lanosterol 14 alpha demethylase inhibitor
0,030  0,026  GABA transporter 3 inhibitor
0,050  0,045  Heparanase inhibitor
0,017  0,012  G-protein-coupled receptor 120 agonist
0,013  0,009  DNA polymerase III polC-type inhibitor
0,039  0,035  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,044  0,040  Glucose-6-phosphate isomerase inhibitor
0,050  0,047  Peristaltic stimulant
0,079  0,076  NADH dehydrogenase inhibitor
0,045  0,042  Bombesin 2 receptor antagonist
0,046  0,043  Squalene epoxidase inhibitor
0,026  0,024  Hedgehog signaling activator
0,084  0,082  UDP-glucose 4-epimerase inhibitor
0,029  0,027  Nucleoside transporters inhibitor
0,109  0,107  Interleukin 1 antagonist
0,064  0,062  Porphobilinogen synthase inhibitor
0,030  0,029  Sodium-dependent vitamin C transporter 2 inhibitor
0,043  0,042  Carbonic anhydrase XIV inhibitor
0,045  0,044  HCV NS3/NS4A protease inhibitor
0,024  0,023  Sodium/glucose cotransporter inhibitor
0,037  0,037  Plasmepsin II inhibitor
0,040  0,039  Fructose-1,6-bisphosphatase inhibitor
0,010  0,010  Calcineurin inhibitor
0,111  0,110  Nav1.6 sodium channel blocker
0,034  0,034  Retinoid X receptor antagonist

